Xie, M., Bao, M., Dong, X., Wu, L., Liu, L., Zhao, J., . . . Su, C. (2025). Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer. Signal Transduction and Targeted Therapy, 10(1), 1. https://doi.org/10.1038/s41392-025-02252-5
Chicago-referens (17:e uppl.)Xie, Mengqing, et al. "Harnessing Local and System Immune Profiling Delineating Differential Responders to First-line Sintilimab (anti-PD-1 Antibody) Combined with Chemotherapy in Extensive-stage Small Cell Lung Cancer." Signal Transduction and Targeted Therapy 10, no. 1 (2025): 1. https://doi.org/10.1038/s41392-025-02252-5.
MLA-referens (9:e uppl.)Xie, Mengqing, et al. "Harnessing Local and System Immune Profiling Delineating Differential Responders to First-line Sintilimab (anti-PD-1 Antibody) Combined with Chemotherapy in Extensive-stage Small Cell Lung Cancer." Signal Transduction and Targeted Therapy, vol. 10, no. 1, 2025, p. 1, https://doi.org/10.1038/s41392-025-02252-5.
